'Up time' diaporamas de présentation

EPI 5344: Survival Analysis in Epidemiology Time varying covariates March 25, 2014

EPI 5344: Survival Analysis in Epidemiology Time varying covariates March 25, 2014. Dr. N. Birkett, Department of Epidemiology & Community Medicine, University of Ottawa. Objectives. Introduce time varying covariates Methods of inclusion into Cox models SAS (computer) issues.

787 views • 67 slides

SENSOR PRODUCTS

SENSOR PRODUCTS. Fixed/Permanent and Portable Flowmeters for Open Channels and Part Filled Pipes http://www.sensor-products.com info@sensor-products.com. SENSOR PRODUCTS. Industrial Effluent Measurement Waste Water Monitoring Sewage Treatment Water Supplies Irrigation Others ??.

603 views • 45 slides

EPI 5344: Survival Analysis in Epidemiology Cox regression: Introduction March 18, 2014

EPI 5344: Survival Analysis in Epidemiology Cox regression: Introduction March 18, 2014. Dr. N. Birkett, Department of Epidemiology & Community Medicine, University of Ottawa. Objectives. Review proportional hazards Introduce Cox model and methods of estimation Tied data.

708 views • 45 slides

PREVENTING HEALTHCARE ACQUIRED CONDITIONS

508 views • 35 slides

This presentation discusses the importance of communication in engineering and some key principles

Key Principles . audience. occasion. purpose. [ Report , 1986]. Importance of Engineering Communications. This presentation discusses the importance of communication in engineering and some key principles . How well you communicate affects your career. Survey (Richard M. Davis)

336 views • 33 slides

Lecture 6: Descriptive follow-up studies

Lecture 6: Descriptive follow-up studies. Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards analysis, hazard ratio . Natural history (clinical course) and prognosis of a disease. Why? Patient/family counseling

491 views • 32 slides

EPIB-591 Screening

452 views • 30 slides

HIV Early Treatment Workshop Planning for removal of the CD4 <500 requirement for prescribing ART

HIV Early Treatment Workshop Planning for removal of the CD4 <500 requirement for prescribing ART. A partnership between . Support for this webinar. Australasian Society for HIV Medicine ACT, NSW, QLD, SA, TAS, VIC, WA governments ViiV Healthcare and Gilead Sciences

415 views • 29 slides

Structure: the Strategy of Style

Structure: the Strategy of Style. If a man can group his ideas, then he is a writer . Robert Louis Stevenson. Ending. Middle. Beginning. The organization of a scientific document can be viewed as a beginning, middle, and ending. Conclusions Back Matter. Ending. Middle Sections. Middle.

321 views • 22 slides

Structure: the Strategy of Style

Structure: the Strategy of Style. If a man can group his ideas, then he is a writer . Robert Louis Stevenson. Ending. Middle. Beginning. The organization of a scientific document can be viewed as a beginning, middle, and ending. Conclusions Back Matter. Ending. Middle Sections. Middle.

363 views • 22 slides

Estimating Project Times and Costs

Chapter 5. Estimating Project Times and Costs. Estimating Projects . Estimating The process of forecasting or approximating the time and cost of completing project deliverables The task of balancing the expectations of stakeholders and the need for control while the project is implemented

664 views • 22 slides

Progress report on Median U-Turn (MUT) planning model

560 views • 21 slides

Just-in-time (JIT) System

Just-in-time (JIT) System. Lean and fast production system. World Class Manufacturing . High quality Low costs Fast delivery. TIME-BASED COMPETITION. TWO TYPES OF PRODUCTION SYSTEM. PRODUCE TO STOCK OR FORECAST OR ACCORDING TO CAPACITY (PUSH TYPE)

867 views • 20 slides

358 views • 20 slides

Vestibular Schwannoma Surgical management and outcomes

Vestibular Schwannoma Surgical management and outcomes. Ching-Jen (Jared) Chen Visiting Sub-Intern University of Virginia. Patient MM. 48yo M w/ L-sided tinnitus and dysequilibrium since 2009. MRI 2010 revealed 5mm L vestibular schwannoma (purely intracanalicular).

608 views • 19 slides

Dr. N. Birkett, Department of Epidemiology & Community Medicine, University of Ottawa

EPI 5344: Survival Analysis in Epidemiology Epi Methods: why does ID involve person-time? March 13, 2014. Dr. N. Birkett, Department of Epidemiology & Community Medicine, University of Ottawa. The Issue (1). Epidemiology focuses on: Incidence Proportion or Cumulative Incidence (CI)

291 views • 19 slides

Neurological Outcomes (Epilepsy) in Clinical Trials for TSC and Related Disorders

Neurological Outcomes (Epilepsy) in Clinical Trials for TSC and Related Disorders. Working Group D. International TSC Research Conference Summit on Drug Discovery in TSC and Related Disorders July 8, 2011. Outline. A. Significance/Problems of Epilepsy in TSC B. Goals of Treatment

270 views • 13 slides

Progression as an endpoint in CRC

Progression as an endpoint in CRC. Kevin Carroll, BSc, MSc, FRSS, Global Statistical Leader, Oncology, AstraZeneca Pharmaceuticals. Progression is a meaningful endpoint in CRC trials.

242 views • 11 slides

Coaching for Improved Performance:

240 views • 10 slides

Coaching for Improved Performance:

227 views • 10 slides